Beijing Sun-Novo Pharmaceutical Research Dividends and Buybacks
Dividend criteria checks 2/6
Beijing Sun-Novo Pharmaceutical Research is a dividend paying company with a current yield of 0.4% that is well covered by earnings.
Key information
0.4%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 3.0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | CN¥0.165 |
| Payout ratio | 8% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 688621 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 688621 has only been paying a dividend for 3 years, and since then payments have fallen.
Dividend Yield vs Market
| Beijing Sun-Novo Pharmaceutical Research Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (688621) | 0.4% |
| Market Bottom 25% (CN) | 0.6% |
| Market Top 25% (CN) | 2.2% |
| Industry Average (Life Sciences) | 1.3% |
| Analyst forecast (688621) (up to 3 years) | 3.0% |
Notable Dividend: 688621's dividend (0.4%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.55%).
High Dividend: 688621's dividend (0.4%) is low compared to the top 25% of dividend payers in the CN market (2.17%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (8.4%), 688621's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (14.6%), 688621's dividend payments are thoroughly covered by cash flows.